COVID-19 vaccination in South Korea
| Date | February 26, 2021 – present |
|---|---|
| Location | South Korea |
| Cause | COVID-19 pandemic in South Korea |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
Vaccination program[edit]
Daily updates are provided by Korea Disease Control and Prevention Agency.[1]
Vaccines delivered per pharmaceutical company as of 4 May 2021 [refresh]
Background[edit]
On 10 February 2021, South Korea granted its first approval of a COVID-19 vaccine to Oxford–AstraZeneca, allowing the two-shot regimen to be administered to all adults, including the elderly. The approval came with a warning, however, that consideration is needed when administering the vaccine to individuals over 65 years of age due to limited data from that demographic in clinical trials.[2][3]
On 14 April 2021, The additional 250,000 doses of Pfizer/BioNTech vaccines arrived the country.[4]
Vaccines on order[edit]
| Vaccine | Progress | Doses ordered | Approval | Deployment | Manufacturer | Remarks |
|---|---|---|---|---|---|---|
| Oxford-AstraZeneca | Approved for use | 20 million |  10 February 2021[5]
|
26 February 2021[6]
|
 SK Bioscience
|
- |
| up to 2.6 million | SK Bioscience
|
COVAX | ||||
| Pfizer–BioNTech | Approved for use | up to 0.1 million |  3 February 2021 (EUA)[7] 5 March 2021[8]
|
27 February 2021[9]
|
 Pfizer
|
COVAX |
| 66 million | Pfizer
|
- | ||||
| Janssen | Approved for use | 6 million | 7 April 2021[10]
|
Pending |  Emergent BioSolutions
|
- |
| Moderna | phase III clinical trials | 40 million | Pending | Pending | unknown | - |
| Novavax | phase III clinical trials | 40 million | Pending | Pending | SK Bioscience
|
- |
Production[edit]
AstraZeneca signed a deal with South Korea's SK Bioscience to manufacture its vaccine products. The collaboration calls for the SK Bioscience to manufacture AZD1222 for local and global markets.[11] The World Health Organization approved AstraZeneca's COVID-19 vaccine for emergency use on February. The initial approval covers doses produced by AstraZeneca and South Korea's SK Bioscience.[12]
South Korea's Korus Pharm has formed a consortium to produce Russia's Sputnik V COVID-19 vaccine. the consortium will produce 500 million doses of the vaccine.[13] However, The Sputnik V doses manufactured in South Korea are not for domestic use.[14] The vaccine is to be exported to Russia and UAE.[15]
Novavax will license out its NVX-CoV2373 vaccine technology to SK Bioscience for contract manufacturing purposes. SK Bioscience will manufacture 40 million doses of Novavax vaccines.[16]
Vaccines in trial stage[edit]
| Vaccine | Type (technology) | Phase I | Phase II | Phase III |
|---|---|---|---|---|
| INO-4800 | DNA | Completed
|
In progress | In progress |
| GX-19 (GX-19N) | DNA | In progress | In progress |  Not Yet
|
| EuCorVac-19 | Subunit | In progress | In progress | Not Yet
|
| GBP510 | Subunit | In progress | In progress | Not Yet
|
| AdCLD-CoV19 | Viral vector | In progress | In progress | Not Yet
|
| GLS-5310 | DNA | In progress | In progress | Not Yet
|
| NBP2001 | DNA | In progress | Not Yet
|
Not Yet
|
References[edit]
- ^ "코로나19 백신 및 예방접종: 안전하고, 신속하게 추진합니다" (Press release) (in Korean). Korea Disease Control and Prevention Agency. Retrieved March 8, 2021.
- ^ Kim, Han-joo (February 10, 2021). "S. Korea approves AstraZeneca's COVID-19 vaccine for all adults". Yonhap News Agency. Retrieved February 10, 2021.
- ^ Maresca, Thomas (February 10, 2021). "South Korea approves AstraZeneca COVID-19 vaccine". UPI. Retrieved February 10, 2021.
- ^ "Coronavirus: South Korea warns of possible fourth wave, Thailand cases surge". South China Morning Post. April 14, 2021. Retrieved April 18, 2021.
- ^ Maresca, Thomas (February 10, 2021). "South Korea approves AstraZeneca COVID-19 vaccine". UPI. Retrieved February 28, 2021.
- ^ Kim, Tong-hyung (February 26, 2021). "South Korea starts vaccinating, but people over 65 must wait". ABC News. Retrieved February 28, 2021.
- ^ Lim, Jeong-yeo (February 3, 2021). "South Korea approves special import of Pfizer vaccine". The Korea Herald. Retrieved February 28, 2021.
- ^ Kim, Han-joo (March 5, 2021). "S. Korea approves Pfizer's COVID-19 vaccine amid immunization push". Yonhap News Agency. Retrieved March 5, 2021.
- ^ Lee, Kyung-eun (February 27, 2021). "S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program". Arirang News. Retrieved February 28, 2021.
- ^ "S. Korea approves Janssen's COVID-19 vaccine". Yonhap News Agency. April 7, 2021. Retrieved April 8, 2021.
- ^ Kim, Yoo-chul (November 30, 2020). "Korea signs agreement with AstraZeneca for COVID vaccine". The Korea Times. Retrieved January 30, 2021.
- ^ Steinhauser, Gabriele (February 15, 2021). "WHO Approves AstraZeneca Covid-19 Vaccine for Emergency Use". The Wall Street Journal. Retrieved March 1, 2021.
- ^ Choi, Moon-hee (February 26, 2021). "South Korean Companies to Produce Russia's Sputnik V Vaccine". Businesskorea. Retrieved March 1, 2021.
- ^ Shim, Elizabeth (February 25, 2021). "South Korean consortium to make 500 million doses of Sputnik V vaccine". UPI. Retrieved March 1, 2021.
- ^ Kim, Byeong-ho (February 23, 2021). "주문량만 6억5000도스, 국내 생산 러 백신 공장 가보니". Maeil Business (in Korean). Retrieved March 1, 2021.
- ^ Lim, Jeong-yeo (February 16, 2021). "SK Bioscience to manufacture Novavax vaccine for 20 mil population". The Korea Herald. Retrieved March 1, 2021.
